This recognition attests to Sun Pharma’s commitment to incorporate Environmental, Social, and Governance (ESG) principles through focused initiatives across its businesses
Indian Pharma Post brings together the views of industry leaders on the Interim Union Budget 2024-25 announcement and its impact on the industry
Union Ayush Minister with Assam Chief Minister lays foundation stone for Central Research Institute of Yoga & Naturopathy
Agreed Price of US$43 per share to deliver 48% premium to unaffected price on May 25, 2023
Bayer has granted the non-exclusive rights to Sun Pharma to market and distribute a second brand of Finerenone under the brand name Lyvelsa
The three-day forum will feature global leaders, scientists, regulatory body representatives, industry associations, and academia among many others
Atlas AI combines NVIDIA BioNeMo cloud APIs for intelligent chemical and protein design
Lays Foundation Stone of 6 new facilities at AIIMS Bhopal and inaugurates a slew of facilities in Madhya Pradesh
The company received gross proceeds of approximately US$1.7 million and net proceeds,
Sirius JV will be owned 51% by Sirius and 49% by Adani
Subscribe To Our Newsletter & Stay Updated
